| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (oxacillin-resistant) |
>16 |
>16 |
0.25 － >16 |
Clindamycin (Cleocin)  |
496 |
| Staphylococcus aureus (oxacillin-resistant) |
>16 |
>32 |
≤0.25 － >32 |
Cephalothin (Cefalotin, Keflin, Seffin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
>30 |
>30 |
0.25 － >30 |
Ofloxacin (Floxin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
0.12 － >32 |
Amoxicillin-clavulanate |
493 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
1 － >32 |
Cefuroxime (Kefurox, Zinacef) |
267 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
2 － >32 |
Cefaclor (Ceclor, Ceclor CD) |
267 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
16 － >32 |
Ceftriaxone (Rocephin) |
267 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
? － ? |
Cefepime (Maxipime) |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
? － ? |
Ceftriaxone (Rocephin) |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
>32 |
>32 |
? － ? |
Imipenem |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
>100 |
>100 |
≤0.12 － >100 |
Clindamycin (Cleocin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
200 |
2 |
0.25 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
>200 |
>200 |
≤0.12 － >200 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
592 |
| Staphylococcus aureus (oxacillin-resistant) |
>256 |
>256 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
>256 |
>256 |
? － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
126 |
| Staphylococcus aureus (oxacillin-resistant) |
- |
4 |
0.5 － 5 |
Linezolid (PNU-100766, U-100766, Zyvox) |
726 |
| Staphylococcus aureus (oxacillin-resistant) |
- |
8 |
>16 － ? |
Chloramphenicol (Chloromycetin) |
39 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.016 |
0.03 |
0.016 － >16 |
Imipenem |
493 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.03 |
≤0.03 |
≤0.03 － 1 |
Trovafloxacin (Trovan) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.032 |
0.064 |
? － ? |
Imipenem |
126 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.06 |
0.015 － 2 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
≤0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
≤0.06 － 0.25 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
? － ? |
Sparfloxacin (AT-4140, Zagam) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
476 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
? － ? |
Clindamycin (Cleocin) |
39 |